SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / April 1, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company"), ...

The total net revenue for the year ended December 31, 2024 of approximately $11.7 million for prescription and non-prescription products, including license revenue, increased approximately 20% versus ...

Shares of Jaguar Health common stock to begin trading on split-adjusted basis on March 24, 2025 ...

Jaguar Health (JAGX) announced the results of a new survey of 27 board certified veterinary oncologists practicing in the U.S. regarding ...

Jaguar is past the point of no return on its pathway to becoming an electric vehicle-only brand, with none of its future models capable of being powered by petrol or diesel engines. Speaking to ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

Comprising three main variants and built from 1948 through 1954, the model combines sumptuous bodywork with impressive brawn.

Jaguar's rebranding and plans for an electric grand tourer—previewed by last year's Type 00 concept—have been polarizing, but there's no going back for the British automaker. In an interview ...

It’s confirmed: Jaguar’s 986-hp electric GT will debut late 2025, with production beginning mid-2026 The GT retains classic Jaguar driving dynamics while achieving an estimated 692-km battery ...